Loading…
Major Korean cosmetics and household/health products maker (Whoo, Ohui, toiletries, beverages), rival to Amorepacific.
Major Korean cosmetics and household/health products maker (Whoo, Ohui, toiletries, beverages), rival to Amorepacific.
Sells cosmetics through department stores, duty-free shops and China, with the luxury Whoo line the profit anchor; household goods and a beverage business that bottles and sells Coca-Cola drinks in Korea give steadier cash. LG Corp is the controlling shareholder.
Moat: narrow (brand, distribution). Whoo is a top luxury K-beauty brand with strong China/duty-free distribution.
Headquarters: Seoul, South Korea · Founded: 1947 · Employees: 4,013
Size LG H&h (051900.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $2.56B, the 114th largest of 495 South Korea companies the cockpit tracks. Shares closed at ₩234,000 on 6 Nov 2026.
Performance Over six months the shares fell 7.9%, against -3.3% for the median peer and -24.5% for the South Korea market (cap-weighted) — 9th lowest of 21 in its peer set.
Growth Revenue fell 3.2% over the last twelve months (peer median +3.5%); the operating margin is 3.3% (peer median 10.4%).
Valuation It trades at 18.5× forward earnings against a peer median of 21.0× (9th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about 0% a year for seven years (Req g). Recent delivered growth is -4%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 2.6 points below its cost of capital (5.4% WACC).
Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩6.28T | ₩6.36T | ₩6.81T | ₩6.80T | ₩7.19T |
| Revenue growth | — | -7% | 0% | -5% | — |
| Gross profit | n/a | ₩3.02T | ₩3.43T | ₩3.48T | ₩3.85T |
| EBITDA | n/a | ₩410B | ₩715B | ₩757B | ₩999B |
| Net income | -₩81.0B | -₩100B | ₩189B | ₩143B | ₩237B |
| Free cash flow | n/a | ₩368B | ₩397B | ₩507B | ₩340B |
| Capital expenditure | n/a | ₩94.6B | ₩147B | ₩164B | ₩166B |
| Total debt | n/a | ₩219B | ₩441B | ₩347B | ₩443B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| LG H&h 051900.KS | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% |
| Amorepacific 090430.KS | $6.03B | -1% | +10% | 9% | 23.8× | 4.0% |
| Cosmax 192820.KS | $2.13B | +21% | +16% | 8% | 16.6× | n/a |
| Estée Lauder Companies (The) EL | $39.9B | +28% | +6% | 13% | 31.1× | 16.8% |
| L'Oreal OR.PA | $268B | +25% | +3% | 21% | 32.8× | 18.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 051900.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -13.7% | +3.1% | 3rd lowest of 21 |
| 6-month return | -7.9% | -3.3% | 9th lowest of 21 |
| Distance from 52-week high | -30.2% | -24.1% | 8th lowest of 21 |
| Revenue growth (TTM) | -3.2% | +3.5% | 3rd lowest of 21 |
| Operating margin | 3.3% | 10.4% | 3rd lowest of 21 |
| Forward P/E | 18.5× | 21.0× | 9th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -0.1% | 4.5% | 9th least demanding of 18 |
| Growth delivered (Del g) | -4.1% | +5.6% | lowest of 18 |
| Hurdle (Req g minus delivered) | +4.0 pp | -3.2 pp | 6th most demanding of 18 |
| ROIC minus cost of capital | -2.6 pp | +5.5 pp | 4th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| LG H&h 051900.KS | South Korea | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% | -4.1% |
| Gillette India GILLETTE.NS | India | $2.56B | -7% | +8% | 28% | 33.0× | 16.0% | +13.0% |
| Winner Medical 300888.SZ | China | $2.69B | -2% | +4% | 11% | 20.9× | -4.3% | -2.6% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |
| Giant Biogene 2367.HK | Hong Kong | $2.76B | -34% | -10% | 32% | 9.7× | -8.0% | +34.9% |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| Proya Cosmetics 603605.SS | China | $2.97B | -19% | +2% | 13% | 11.1× | -4.8% | +23.1% |
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| Lion 4912.T | Japan | $3.19B | +21% | +6% | 8% | 19.9× | -2.4% | +3.5% |
| Hengan Int'l 1044.HK | Hong Kong | $3.28B | -16% | +2% | 11% | 9.1× | -8.8% | -0.1% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.29B | +20% | +4% | 6% | 50.2× | 17.6% | +1.9% |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| Coty COTY | United States | $3.57B | +64% | -1% | 5% | 13.3× | 11.3% | +4.6% |
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Interparfums ITP.PA | France | $3.65B | +72% | -4% | 18% | 27.5× | 15.9% | +19.6% |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |
| Pigeon 7956.T | Japan | $1.66B | +30% | +7% | 13% | 26.3× | -1.3% | +1.9% |